Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
19.57
Price to sales ratio
3.2

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
788
ELAN
Elanco Animal Health Incorporated Common Stock
25.15 USD+1.33%-0.20%+1.70%+12.30%12.56 B USD
876
RDY
Dr. Reddy's Laboratories Ltd
12.92 USD-2.12%-9.84%-3.51%-11.93%10.78 B USD
1120
LNTH
Lantheus Holdings, Inc. - Common Stock
105.39 USD-0.24%+3.83%+0.59%+88.00%6.86 B USD
1275
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
17.18 USD+1.00%+0.29%+6.58%+62.84%5.48 B USD

Frequently asked questions about Alkermes plc - Ordinary Shares

What is the Alkermes plc - Ordinary Shares stock price today?

The current price of Alkermes plc - Ordinary Shares (ALKS) is 51.87. Over the past 24 hours, the stock has changed by -0.13%. Follow the ALKS chart for real-time price dynamics.

What is the stock ticker of Alkermes plc - Ordinary Shares?

Alkermes plc - Ordinary Shares trades under the ticker ALKS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Alkermes plc - Ordinary Shares stock going up?

ALKS has changed by -6.32% over the last week, +17.57% over the last month, and +73.25% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Alkermes plc - Ordinary Shares net income for the last quarter?

Alkermes plc - Ordinary Shares reported net income of -66.48 M for the last quarter. The previous quarter showed 49.34 M, which means net income changed by -234.74%.

How many employees does Alkermes plc - Ordinary Shares have?

As of the latest available data, Alkermes plc - Ordinary Shares has 2 050 employees. Workforce size can provide additional context about the company's scale and operations.

What is Alkermes plc - Ordinary Shares EBITDA?

Alkermes plc - Ordinary Shares EBITDA is -28.85 M, and its EBITDA margin is -7.34%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Alkermes plc - Ordinary Shares stock?

You can buy Alkermes plc - Ordinary Shares (ALKS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Alkermes plc - Ordinary Shares stock?

Investing in Alkermes plc - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ALKS chart and related analysis on metatrader.com as part of your research.

Alkermes plc - Ordinary Shares

Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio.

News